/
Other
Abuse Potential
0
Pipeline Programs↗
1
Active Trials↗
20
Companies Involved↗
Abuse Potential is an early-stage landscape with 0 programs across 20 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
46
clinical trials
Completed40 · 87%
Terminated3 · 7%
Withdrawn1 · 2%
Recruiting1 · 2%
Unknown status1 · 2%
Clinical Trials
Trial Activity
46 trials
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)